Sapkale B, Sawal A (2023) Attention deficit hyperactivity disorder (ADHD) causes and diagnosis in adults: a review. Cureus 15(11):e49144

PubMed  PubMed Central  Google Scholar 

Vold JH, Halmøy A, Chalabianloo F, Pierron MC, Løberg E-M, Johansson KA et al (2023) Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study. BMC Psychiatry 23(1):479

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scandurra V, Emberti Gialloreti L, Barbanera F, Scordo MR, Pierini A, Canitano R (2019) Neurodevelopmental disorders and adaptive functions: a study of children with autism spectrum disorders (ASD) and/or attention deficit and hyperactivity disorder (ADHD). Front Psychiatry 10:673

Article  PubMed  PubMed Central  Google Scholar 

Abdelnour E, Jansen MO, Gold JA (2022) ADHD diagnostic trends: increased recognition or overdiagnosis? Mo Med 119(5):467–473

PubMed  PubMed Central  Google Scholar 

Li Y, Yan X, Li Q, Li Q, Xu G, Lu J et al (2023) Prevalence and trends in diagnosed ADHD among US children and adolescents, 2017–2022. JAMA Netw Open 6(10):e2336872

Article  PubMed  PubMed Central  Google Scholar 

Schein J, Adler LA, Childress A, Cloutier M, Gagnon-Sanschagrin P, Davidson M et al (2022) Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. J Med Econ 25(1):193–205

Article  PubMed  Google Scholar 

Schein J, Adler LA, Childress A, Gagnon-Sanschagrin P, Davidson M, Kinkead F et al (2022) Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. J Manag Care Spec Pharm 28(2):168–179

PubMed  Google Scholar 

Balazs J, Kereszteny A (2017) Attention-deficit/hyperactivity disorder and suicide: a systematic review. World J Psychiatry 7(1):44–59

Article  PubMed  PubMed Central  Google Scholar 

Kosheleff AR, Mason O, Jain R, Koch J, Rubin J (2023) Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment. J Atten Disord 27(7):669–697

Article  PubMed  PubMed Central  Google Scholar 

Adamou M, Arif M, Asherson P, Aw T-C, Bolea B, Coghill D et al (2013) Occupational issues of adults with ADHD. BMC Psychiatry 13:59

Article  PubMed  PubMed Central  Google Scholar 

Sharma A, Couture J (2014) A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 48(2):209–225

Article  PubMed  Google Scholar 

Saboory E, Ghasemi M, Mehranfard N (2020) Norepinephrine, neurodevelopment and behavior. Neurochem Int 135:104706

Article  CAS  PubMed  Google Scholar 

Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG (2019) Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol 39(1):31–59

Article  PubMed  Google Scholar 

Functional Roles of Norepinephrine and Dopamine in ADHD [Internet]. [cited 2024 Apr 9]. https://www.medscape.org/viewarticle/523887

Curatolo P, D’Agati E, Moavero R. The neurobiological basis of ADHD. Italian Journal of Pediatrics [Internet]. 2010;36(1):79. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016271/ ‌

Pliszka SR, McCracken JT, Maas JW (1996) Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 35(3):264–272

Article  CAS  PubMed  Google Scholar 

Faraone SV (2018) The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev 87:255–270

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reddy DS (2013) Current pharmacotherapy of attention deficit hyperactivity disorder. Drugs Today 49(10):647–665

Article  CAS  Google Scholar 

Verghese C, Abdijadid S (2023) Methylphenidate [Internet]. Nih.gov. StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482451/ ‌

Martin D, Le JK (2023) Amphetamine [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556103/ ‌

DeLorenzo C, Lichenstein S, Schaefer K, Dunn J, Marshall R, Organisak L et al (2011) SEP-225289 serotonin and dopamine transporter occupancy: a PET study. J Nucl Med 52(7):1150–1155

Article  PubMed  Google Scholar 

Schreiber R, Campbell U, Quinton MS, Hardy LW, Fang QK, Lew R (2022) In vitro and in vivo pharmacological characterization of dasotraline, a dual dopamine and norepinephrine transporter inhibitor in vivo. Biomed Pharmacother 153:113359

Article  CAS  PubMed  Google Scholar 

Hopkins SC, Sunkaraneni S, Skende E, Hing J, Passarell JA, Loebel A et al (2016) Pharmacokinetics and exposure-response relationships of dasotraline in the treatment of attention-deficit/hyperactivity disorder in adults. Clin Drug Investig 36(2):137–146

Article  CAS  PubMed  Google Scholar 

Chen Y-L, Skende E, Lin J, Yi Y, Wang PL, Wills S et al (2017) Absorption, distribution, metabolism, and excretion of [14 C]-dasotraline in humans. Pharmacol Res Perspect 5(1):e00281

Article  PubMed  Google Scholar 

Wigal S, Tsai J, Bates JA, Sarma K, Tortorich D, Zhu H et al (2022) A randomized, placebo-controlled laboratory classroom study of the efficacy and safety of dasotraline in children with ADHD. J Atten Disord 26(10):1357–1368

Article  PubMed  Google Scholar 

Findling RL, Adler LA, Spencer TJ, Goldman R, Hopkins SC, Koblan KS et al (2019) Dasotraline in children with attention-deficit/Hyperactivity disorder: a six-week, placebo-controlled, fixed-dose trial. J Child Adolesc Psychopharmacol 29(2):80–89

Article  CAS  PubMed  Google Scholar 

Koblan KS, Hopkins SC, Sarma K, Jin F, Goldman R, Kollins SH et al (2015) Dasotraline for the treatment of attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled, proof-of-concept trial in adults. Neuropsychopharmacology 40(12):2745–2752

Article  CAS  PubMed  PubMed Central  Google Scholar 

McElroy SL, Hudson JI, Grilo CM, Guerdjikova AI, Deng L, Koblan KS et al (2020) Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, flexible-dose clinical trial. J Clin Psychiatry 81(5)

Halevy-Yosef R, Bachar E, Shalev L, Pollak Y, Enoch-Levy A, Gur E et al (2019) The complexity of the interaction between binge-eating and attention. PLoS ONE 14(4):e0215506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Article  PubMed  PubMed Central  Google Scholar 

Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training [Internet]. [cited 2024 Apr 10]. https://training.cochrane.org/handbook/current

Rayyan – Intelligent Systematic Review - Rayyan [Internet]. [cited 2024 Apr 10]. https://www.rayyan.ai/

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928

Article  PubMed  PubMed Central  Google Scholar 

Döpfner M, Steinhausen H-C, Coghill D, Dalsgaard S, Poole L, Ralston SJ et al (2006) Cross-cultural reliability and validity of ADHD assessed by the ADHD rating scale in a pan-european study. Eur Child Adolesc Psychiatry 15(Suppl 1):I46–55

Article  PubMed  Google Scholar 

Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4(7):28–37

PubMed  Google Scholar 

Wigal SB, Gupta S, Guinta D, Swanson JM (1998) Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull 34(1):47–53

CAS  PubMed  Google Scholar 

Murray DW, Bussing R, Fernandez M, Wei Hou, Garvan CW, Swanson JM et al (2009) Psychometric properties of teacher SKAMP ratings from a community sample. Assessment 16(2):193–208

Article  PubMed  Google Scholar 

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB et al (2011) Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. J Chi